AAAAAA

   
Results: 1-12 |
Results: 12
LONG-DURATION OF RESPONSE WITH LETROZOLE 2.5 MG (FEMARA(R)) IN 2 TRIALS IN POSTMENOPAUSAL WOMEN WITH ADVANCED BREAST-CANCER AFTER ANTIESTROGEN THERAPY
Authors: GARDIN G FORNASIERO A ROMIEU G BUZZI F CHAUDRI HA LASSUS M
Citation: G. Gardin et al., LONG-DURATION OF RESPONSE WITH LETROZOLE 2.5 MG (FEMARA(R)) IN 2 TRIALS IN POSTMENOPAUSAL WOMEN WITH ADVANCED BREAST-CANCER AFTER ANTIESTROGEN THERAPY, European journal of cancer, 34, 1998, pp. 46-46
LETROZOLE, A NEW ORAL AROMATASE INHIBITOR - RANDOMIZED TRIAL COMPARING 2.5MG DAILY, 0.5MG DAILY AND AMINOGLUTETHIMIDE IN POSTMENOPAUSAL WOMEN WITH ADVANCED BREAST-CANCER
Authors: GERSHANOVICH M CHAUDRI HA CAMPOS D LURIE H BONAVENTURA A JEFFREY M BUZZI F BODROGI I LUDWIG H REICHARDT P OHIGGINS N ROMIEU G FRIEDERICH P LASSUS M
Citation: M. Gershanovich et al., LETROZOLE, A NEW ORAL AROMATASE INHIBITOR - RANDOMIZED TRIAL COMPARING 2.5MG DAILY, 0.5MG DAILY AND AMINOGLUTETHIMIDE IN POSTMENOPAUSAL WOMEN WITH ADVANCED BREAST-CANCER, Annals of oncology, 9(6), 1998, pp. 639-645
TOLERABILITY OF HIGH-DOSE CYCLOPHOSPHAMIDE AND CARBOPLATINUM FOLLOWEDBY CM-CSF INFUSION
Authors: CINIERI S DICLEMENTE F MANCINI S FERRAJOLI A GENUA A ADAMO S DICOSTANZO F BUZZI F BISCOTTINI B LIBERATI AM
Citation: S. Cinieri et al., TOLERABILITY OF HIGH-DOSE CYCLOPHOSPHAMIDE AND CARBOPLATINUM FOLLOWEDBY CM-CSF INFUSION, European journal of cancer, 31A, 1995, pp. 253-253
ONDANSETRON VERSUS GRANISETRON, BOTH COMBINED WITH DEXAMETHASONE, IN THE PREVENTION OF CISPLATIN-INDUCED EMESIS
Authors: BASURTO C CICCARESE G PALLADINO MA PICCIAFUOCO M RICCI S ANTONUZZO A ALLEGRINI G CONTE PF COGNETTI F CIRULLI S COLELLA E MILELLA M SAVARESE A STANI S CONTU A OLMEO N PIRO S PIRAS M PILO L PILO P NUZZO A URSINI LA TARABORRELLI M MELENA S BASILICO L BUZZI F BRUGIA M TRIPPA F DELRIO S TAGLIAVENTI M PICECE V CASSANDRINI P CIRILLO M MAGAROTTO R RECALDIN E CLERICO M BARTETTO O MORANDINI MP BAINOTTI L BONI C MORETTI G SAVOLDI L TATEO S CHIAPPARINI I ZARA C CATALANO G CASCINU S ALESSANDRONI P MASSIDDA B IONTA MT PEDDITZI E MONTINARI F CASARTELLI C MANDELLI D ROTONDO SG LELLI G CILENTI G MORRITTI M PUSCEDDU G SALARIS G PRESTI ML FAVALLI G GAMBINO A RAVELLI V CORTESI E GIOACCHINI N OLIVA A DAZZI C MONTANARI L CRUCIANI G DEMARINIS F SCARFONE G BOLIS MC SCAGLIOTTI G SELVAGGI G DONATI D MALACARNE P SANTORO A PARRA HS LOCATELLI MC LUPORINI G SANSONI E MATERA G FAVA C
Citation: C. Basurto et al., ONDANSETRON VERSUS GRANISETRON, BOTH COMBINED WITH DEXAMETHASONE, IN THE PREVENTION OF CISPLATIN-INDUCED EMESIS, Annals of oncology, 6(8), 1995, pp. 805-810
CISPLATIN AND VP16 IN METASTATIC BREAST-CARCINOMA AS A 3RD-LINE CHEMOTHERAPY - A RANDOMIZED STUDY COMPARING LOW VERSUS HIGH-DOSES OF CISPLATIN
Authors: CECI G BISAGNI G COCCONI G RODINO C BELSANTI V BERTUSI M BUZZI F BACCHI M
Citation: G. Ceci et al., CISPLATIN AND VP16 IN METASTATIC BREAST-CARCINOMA AS A 3RD-LINE CHEMOTHERAPY - A RANDOMIZED STUDY COMPARING LOW VERSUS HIGH-DOSES OF CISPLATIN, Tumori, 81(4), 1995, pp. 241-244
NATURAL INTERFERON-BETA AND TAMOXIFEN IN HORMONE-RESISTANT PATIENTS WITH ADVANCED BREAST-CANCER
Authors: BUZZI F BRUGIA M TRIPPA F ROSSI G TRIVISONNE R GIUSTINI L PINAGLIA D CAPPARELLA V SICA G
Citation: F. Buzzi et al., NATURAL INTERFERON-BETA AND TAMOXIFEN IN HORMONE-RESISTANT PATIENTS WITH ADVANCED BREAST-CANCER, Anticancer research, 15(5), 1995, pp. 2187-2189
ONDANSETRON PLUS DEXAMETHASONE VERSUS METOCLOPRAMIDE PLUS DEXAMETHASONE PLUS DIPHENHYDRAMINE IN CISPLATIN-TREATED PATIENTS WITH OVARIAN-CANCER
Authors: FAVALLI G ROILA F TONATO M DEANGELIS V BALLATORI E DELFAVERO A BASURTO C CORGNA E PALLADINO MA PICCIAFUOCO M CICCARESE G PATOIA L GARBELLI R BIANCHI UA SCARFONE G FERRARIS C BOLIS MC COGNETTI F COLELLA E BUZZI F DELRIO S SABBATINI R SILINGARDI V MATERA G CELLERINO R DAZZI C MARANGOLO M LEONARDI M CANALETTI R BABILONTI L ZARA C DONATI D AMADORI D FERRARI M
Citation: G. Favalli et al., ONDANSETRON PLUS DEXAMETHASONE VERSUS METOCLOPRAMIDE PLUS DEXAMETHASONE PLUS DIPHENHYDRAMINE IN CISPLATIN-TREATED PATIENTS WITH OVARIAN-CANCER, Supportive care in cancer, 2(3), 1994, pp. 167-170
ON THE RELATIONSHIP BETWEEN NAUSEA AND VOMITING IN PATIENTS UNDERGOING CHEMOTHERAPY
Authors: DEANGELIS V BALLATORI E ROILA F TONATO M DELFAVERO A BASURTO C BRACARDA S CORGNA E PICCIAFUOCO M PATOIA L FAVALLI G GARBELLI R BIANCHI UA SCARFONE G FERRARIS C BOLIS MC COGNETTI F COLELLA E BUZZI F DELRIO S SABBATINI R FEDERICO M MATERA G CELLERINO R DAZZI C MARANGOLO M LEONARDI M CANALETTI R BABILONTI L ZARA C DONATI D AMADORI D FERRARI M
Citation: V. Deangelis et al., ON THE RELATIONSHIP BETWEEN NAUSEA AND VOMITING IN PATIENTS UNDERGOING CHEMOTHERAPY, Supportive care in cancer, 2(3), 1994, pp. 171-176
CISPLATIN-INDUCED DELAYED EMESIS - PATTERN AND PROGNOSTIC FACTORS DURING 3 SUBSEQUENT CYCLES
Authors: ROILA F TONATO M DEANGELIS V BALLATORI E OLIVIERI A DELFAVERO A BASURTO C CORGNA E PICCIAFUOCO M PALLADINO MA CICCARESE G FAVALLI G GARBELLI R BIANCHI UA SCARFONE G FERRARIS C BOLIS MC COGNETTI F CERCATO MC BUZZI F TRIPPA F SABBATINI R SILINGARDI V MATERA G GRAMAZIO A DAZZI C MARANGOLO M LEONARDI M CANALETTI R TATEO S ZARA C DONATI D SANSONI E FERRARI M
Citation: F. Roila et al., CISPLATIN-INDUCED DELAYED EMESIS - PATTERN AND PROGNOSTIC FACTORS DURING 3 SUBSEQUENT CYCLES, Annals of oncology, 5(7), 1994, pp. 585-589
DIFFERENCE IN PERSISTENCE OF EFFICACY OF 2 ANTIEMETIC REGIMENS ON ACUTE EMESIS DURING CISPLATIN CHEMOTHERAPY
Authors: ROILA F DELFAVARO A BALLATORI E OLIVIERI A TONATO M DEANGLIS V BASURTO C BRACARDA S CORGNA E PICCIAFUOCO M PATOIA L FAVAUI G GARBELLI R BIANCHI UA SCARFONE G FERRARIS C BOLIS MC COGNETTI F COLELLA E BUZZI F DELRIO S SABBATINI R FEDERICO M MATERA G CELLERINO R DAZZI C MARANGGLO M LEONARDI M CANALETTI R BABILONTI L ZARA C DONATI D AMADORI D FERRARI M
Citation: F. Roila et al., DIFFERENCE IN PERSISTENCE OF EFFICACY OF 2 ANTIEMETIC REGIMENS ON ACUTE EMESIS DURING CISPLATIN CHEMOTHERAPY, Journal of clinical oncology, 11(12), 1993, pp. 2396-2404
SALVAGE TREATMENT AFTER RINTERFERON-ALPHA-2A IN ADVANCED NEUROENDOCRINE TUMORS
Authors: ZILEMBO N BUZZONI R BAJETTA E DIBARTOLOMEO M DEBRAUD F CASTELLANI R MAFFIOLI L CELIO L VILLA E LORUSSO V FOSSER V BUZZI F
Citation: N. Zilembo et al., SALVAGE TREATMENT AFTER RINTERFERON-ALPHA-2A IN ADVANCED NEUROENDOCRINE TUMORS, Acta oncologica, 32(2), 1993, pp. 245-250
TREATMENT OF METASTATIC CARCINOIDS AND OTHER NEUROENDOCRINE TUMORS WITH RECOMBINANT INTERFERON-ALPHA-2A - A STUDY BY THE ITALIAN TRIALS IN MEDICAL ONCOLOGY GROUP
Authors: BAJETTA E ZILEMBO N DIBARTOLOMEO M DILEO A PILOTTI S BOCHICCHIO AM CASTELLANI R BUZZONI R CELIO L DOGLIOTTI L PINOTTI G AITINI E LABIANCA R FORNASIERO A RIVA P SCHIEPPATI G NELLI P MARIANI L ATTARD M BARDUAGNI M BELLU F BUZZI F DAPRILE M DEMARINO E EPIFANI C FARINA G FATTORI PP FERRERO B FOSSER V IIRILLO A LORUSSO V MAIFREDI G MEROZZI P PASINI F SARTI EL SCANNI A VERUSIO C VILLA E
Citation: E. Bajetta et al., TREATMENT OF METASTATIC CARCINOIDS AND OTHER NEUROENDOCRINE TUMORS WITH RECOMBINANT INTERFERON-ALPHA-2A - A STUDY BY THE ITALIAN TRIALS IN MEDICAL ONCOLOGY GROUP, Cancer, 72(10), 1993, pp. 3099-3105
Risultati: 1-12 |